John Bridgewater
约翰·布里奇沃特
MB BChir, PhD, FRCP
Professor of Gastrointestinal Oncology; Consultant Medical Oncologist胃肠肿瘤学教授；肿瘤内科顾问医师
👥Biography 个人简介
John Bridgewater, MB BChir, PhD, FRCP is Professor of Gastrointestinal Oncology at UCL Cancer Institute and a leading UK authority on cholangiocarcinoma biology and clinical research. He has advanced understanding of the molecular pathogenesis of biliary tract cancers and led major UK clinical trials, including ISAC and collaborative studies exploring novel therapeutic strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Cholangiocarcinoma Molecular Biology
Conducted foundational research into the molecular heterogeneity and tumor microenvironment of cholangiocarcinoma, identifying mechanisms of treatment resistance and informing new therapeutic strategies.
ISAC and UK Biliary Tract Cancer Trials
Led the ISAC trial and other UK-based clinical investigations of novel agents in biliary tract cancer, advancing treatment options and contributing to international trial design.
Representative Works 代表性著作
Molecular stratification of cholangiocarcinoma: correlation of the morphological classification with molecular profiling
Gut (2014)
Seminal study correlating morphological subtypes of cholangiocarcinoma with distinct molecular profiles, informing biomarker-driven clinical trial design.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 约翰·布里奇沃特 的研究动态
Follow John Bridgewater's research updates
留下邮箱，当我们发布与 John Bridgewater（UCL Cancer Institute, University College London）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment